The common involvement of the mTOR pathway genes has been demonstrated in this tumor, further supported by the expression of the mTOR pathway activation markers p-S6 and p-4EBP1 [37,44,45,47]; conversely, these tumors lack complete chromosomal gains or losses, as well as CCND1 rearrangements [43]. Here, MTOR is linked to neoplasm.